Paxeladine® [Oxeladine Citrate]

Pharmacological properties

non-opiate, non-antihistamine central antitussive.

Pharmacokinetics The pharmacokinetics of oxeladine are very limited.

Indications

Symptomatic treatment of difficult unproductive cough.

Application

The drug is prescribed for adults and children aged 2.5 years and weighing at least 15 kg. short-term treatment (2-3 days) immediately after the occurrence of cough.

The package contains a measuring spoon of 2.5 and 5 ml, which corresponds to 5 and 10 mg of oxeladine citrate.

Children with a body weight of 15–20 kg (age from 2.5 years to 6 years) are prescribed 1 spoon (2.5 ml) of syrup every 4 hours. The maximum dose is 3-4 measured spoons per day, depending on body weight a child.

Children weighing 20-30 kg (age 6-10 years) are prescribed 1 spoon (5 ml) of syrup every 4 hours. The maximum dose is 2-3 measured spoons per day, depending on the body weight of the child.

Children with a body weight of 30-50 kg (age 10-15 years) are prescribed 1 spoon (5 ml) of syrup every 4 hours. The maximum dose is 3-5 measured spoons per day, depending on the body weight of the child.

If necessary, adults are prescribed 1 spoon (5 ml) of syrup every 4 hours. The maximum dose is 5 scoops per day.

Contraindications

Hypersensitivity to any of the components of the drug.

Side effects

Hypersensitivity reactions, including urticaria, rash, itching, flushing of the skin, angioedema.

special instructions

Paxeladine should not be used to treat a productive cough; this can make sputum discharge difficult.

Paxeladine should not be used simultaneously with mucolytic and expectorant drugs.

Before using the drug, it is necessary to determine the etiology of cough.

If the cough does not stop when using the recommended doses, you should not increase the dose, but you need to consult a doctor.

It is necessary to take into account the sugar content of 4.25 mg in a 5 ml scoop and 2.125 mg in a 2.5 ml syrup in case of diabetes or a low sugar diet.

The product contains sucrose. Patients with rare hereditary diseases of fructose intolerance, glucose-galactose malabsorption, or sucrose-isomaltase deficiency should not use Pakseladin.

The drug contains a small amount of ethanol (alcohol), 24 mg in a teaspoon per 5 ml and 12 mg in a teaspoon per 2.5 ml of syrup.

Use during pregnancy and lactation. It is not recommended to use the drug during pregnancy and lactation.

Children. Given the lack of data on efficacy and safety, it is not recommended to use this drug in children under the age of 2.5 years.

The drug can be used in children over the age of 2.5 years and weighing at least 15 kg.

The ability to influence the reaction rate when driving vehicles or working with other mechanisms. Does not affect.

Interactions

Incompatibility. not installed.

Overdose

Information on the frequency of overdose is limited; however, overdose reports did not report symptoms.

Storage conditions

In the original packaging at a temperature not exceeding 25 ° C out of the reach of children.